Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP319057.RAvmaZgddvYjo9C3HccXEoKKxZpx67-RbOCxfOCgYLyOA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP319057.RAvmaZgddvYjo9C3HccXEoKKxZpx67-RbOCxfOCgYLyOA130_assertion type Assertion NP319057.RAvmaZgddvYjo9C3HccXEoKKxZpx67-RbOCxfOCgYLyOA130_head.
- NP319057.RAvmaZgddvYjo9C3HccXEoKKxZpx67-RbOCxfOCgYLyOA130_assertion wasGeneratedBy ECO_0000203 NP319057.RAvmaZgddvYjo9C3HccXEoKKxZpx67-RbOCxfOCgYLyOA130_provenance.
- NP319057.RAvmaZgddvYjo9C3HccXEoKKxZpx67-RbOCxfOCgYLyOA130_assertion wasDerivedFrom befree-20140225 NP319057.RAvmaZgddvYjo9C3HccXEoKKxZpx67-RbOCxfOCgYLyOA130_provenance.
- NP319057.RAvmaZgddvYjo9C3HccXEoKKxZpx67-RbOCxfOCgYLyOA130_assertion SIO_000772 23596146 NP319057.RAvmaZgddvYjo9C3HccXEoKKxZpx67-RbOCxfOCgYLyOA130_provenance.
- NP319057.RAvmaZgddvYjo9C3HccXEoKKxZpx67-RbOCxfOCgYLyOA130_assertion evidence source_evidence_literature NP319057.RAvmaZgddvYjo9C3HccXEoKKxZpx67-RbOCxfOCgYLyOA130_provenance.
- NP319057.RAvmaZgddvYjo9C3HccXEoKKxZpx67-RbOCxfOCgYLyOA130_assertion description "[As almost all patients with high-risk neuroblastomas have autograft, we aimed to determine if minimal residual disease (MRD) quantified by RT-PCR for tyrosine hydroxylase in PBSC is prognostic in neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP319057.RAvmaZgddvYjo9C3HccXEoKKxZpx67-RbOCxfOCgYLyOA130_provenance.